Agents and Actions

, Volume 17, Issue 3–4, pp 284–289 | Cite as

Multiple control of inflammation by glucocorticoids

  • M. Di Rosa
  • A. Calignano
  • R. Carnuccio
  • A. Ialenti
  • L. Sautebin
Corticosteroid Actions in Infalmmation

Keywords

Glucocorticoid Multiple Control 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    A. Danon andG. Assouline,Inhibition of prostaglandin biosynthesis by corticosteroids requires RNA and protein synthesis, Nature273, 552–554 (1978).PubMedGoogle Scholar
  2. [2]
    M. Di Rosa andP. Persico,Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leucocytes, Br. J. Pharmacol.66, 161–163 (1979).PubMedGoogle Scholar
  3. [3]
    R. Carnuccio, M. Di Rosa andP. Persico,Hydrocortisone induced inhibitor of prostaglandin biosynthesis in rat leucocytes, Br. J. Pharmacol.68, 14–16 (1980).PubMedGoogle Scholar
  4. [4]
    G.J. Blackwell, R. Carnuccio, M. Di Rosa, R.J. Flower, L. Parente andP. Persico,Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids, Nature287, 147–149 (1980).CrossRefPubMedGoogle Scholar
  5. [5]
    F. Hirata, E. Schiffman, K. Venkatasubramanian, D. Salomon andJ. Axelrod,A phospholipase A 2 inhibitory protein in rabbit neutrophils induced by glucocorticoids, Proc. natn. Acad. Sci. USA77, 2533–2536 (1980).Google Scholar
  6. [6]
    J.F. Cloix, O. Colard, B. Rothhut andF. Russo-Marie,Characterization and partial purification of ‘renocortins’: two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids, Br. J. Pharmacol.79, 313–321 (1983).PubMedGoogle Scholar
  7. [7]
    G.J. Blackwell, R. Carnuccio, M. Di Rosa, R.J. Flower, C.S.J. Langham, L. Parente, P. Persico, N.C. Russel-Smith andD. Stone,Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat, Br. J. Pharmacol.76, 185–194 (1982).PubMedGoogle Scholar
  8. [8]
    F. Hirata, M. Notsu, M. Iwata, L. Parente, M. Di Rosa andR.J. Flower,Identification of several species of phospholipase inhibitory proteins by radio-immunoassay for lipomodulin, Biochem. biophys. Res. Commun.109, 223–230 (1982).CrossRefPubMedGoogle Scholar
  9. [9]
    P. Coote, M. Di Rosa, R.J. Flower, L. Parente, M. Merrett andJ.N. Wood,Detection and isolation of a steroid-induced anti-phospholipase protein of high molecular weight, Br. J. Pharmacol.80, 597P (1983).Google Scholar
  10. [10]
    B. Rothhut, F. Russo-Marie, J. Wood, M. Di Rosa andR.J. Flower,Further characterization of the glucocorticoid-induced anti-phospholipase protein ‘renocortin’, Biochem. biophys. Res. Commun.117, 878–884 (1983).CrossRefPubMedGoogle Scholar
  11. [11]
    M. Di Rosa, R.J. Flower, F. Hirata, L. Parente andF. Russo-Marie,Antiphospholipase proteins, Prostaglandins28, 441–442 (1984).CrossRefPubMedGoogle Scholar
  12. [12]
    G.J. Blackwell, R. Carnuccio, M. Di Rosa, R.J. Flower, J. Ivanyi, C.S. Langham, L. Parente, P. Persico andJ. Wood,Suppression of arachidonate oxidation by glucocorticoid-induced anti-phospholipase peptides, Adv. Prost. Thromb. Leukotr. Res.11, 65–71 (1983).Google Scholar
  13. [13]
    L. Parente, M. Di Rosa, R.J. Flower, P. Ghiara, R. Meli, P. Persico, J.A. Salmon andJ.N. Wood,Relationship between the anti-phospholipase and anti-inflammatory effect of glucocorticoid-induced proteins, Eur. J. Pharmac.99, 233–239 (1984).CrossRefGoogle Scholar
  14. [14]
    T. Hattori, T. Hoffman andF. Hirata,Differentiation of a histiocytic lymphoma cell line by lipomodulin, a phospholipase inhibitory protein, Biochem. biophys. Res. Commun.111, 551–559 (1983).CrossRefPubMedGoogle Scholar
  15. [15]
    T. Uede, F. Hirata, M. Hirashima andK. Ishizaka,Modulation of the biological activities of IgE-binding factor, I. Identification of glycosilation-inhibiting factor as a fragment of lipomodulin, J. Immunol.130, 878–884 (1983).PubMedGoogle Scholar
  16. [16]
    M. Koltai, I. Lepran, G.Y. Nemecz andL. Szekeres,The possible mechanism of protection by dexamethasone against sudden death due to coronary ligation in conscious rats, Br. J. Pharmac.79, 327–329 (1983).Google Scholar
  17. [17]
    F. Hirata, R. Del Carmine, C.A. Nelson, J. Axelrod, E. Schiffmann, A. Warabi et al.,Presence of autoantibody for phospholipase inhibitory protein lipomodulin, in patients with rheumatic diseases, Proc. natn. Acad. Sci. USA78, 3190–3194 (1981).Google Scholar
  18. [18]
    G. Ciabattoni, P. Patrignani, P. Filabozzi, A. Pierucci, B. Simonetti, G.A. Cinotti, E. Pinca, E. Gotti, G. Remuzzi andC. Patrono,Increased renal thromboxane (TX) production in systemic lupus erythematosus (SLE), Clin. Res.30, 445A (1982).Google Scholar
  19. [19]
    A. Calignano, R. Carnuccio, M. Di Rosa, A. Ialenti andS. Moncada,The anti-inflammatory effect of glucocorticoid-induced phospholipase inhibitory proteins, Agents and Actions16, 60–62 (1985).PubMedGoogle Scholar
  20. [20]
    M. Di Rosa andD.A. Willoughby,Screens for anti-inflammatory drugs, J. Pharm. Pharmac.23, 297–298 (1971).Google Scholar
  21. [21]
    Y. Ōyanagui,Steroid-like anti-inflammatory effect of superoxide dismutase in serotonin, histamine, and kinin-induced oedemata of mice, Existence of vascular permeability regulating proteins(s), Biochem. Pharmac.30, 1791–1798 (1981).CrossRefGoogle Scholar
  22. [22]
    Y. Ōyanagui,Anti-inflammatory effects of polyamines in serotonin and carrageenin paw oedemata—possible mechanism to increase vascular permeability inhibitory protein level which is regulated by glucocorticoids and superoxide radical, Agents and Actions14, 81–89 (1984).Google Scholar
  23. [23]
    A.H. Janoski, J.C. Shaver, N.P. Christy andW. Rosner,On the pharmacologic actions of 21-carbon hormonal steroids (‘glucocorticoids’) of the adrenal cortex in mammals, Handb. of Expt. Pharmacol.14/3, 256–368 (1968).Google Scholar
  24. [24]
    E.R. Ramey andM.S. Goldstein,The adrenal cortex and the sympathetic nervous system, Physiol. Rev.37, 155–195 (1957).PubMedGoogle Scholar
  25. [25]
    I. Fritz andR. Levine,Action of adrenal cortical steroids and nor-epinephrine on vascular responses of stress in adrenalectomized rats, Am. J. Physiol.165, 456–465 (1951).PubMedGoogle Scholar
  26. [26]
    B.W. Zweifach, E. Shorr andM.M. Black,The influence of the adrenal cortex on behavior of terminal vascular bed, Ann. N.Y. Acad. Sci.56, 626–633 (1953).PubMedGoogle Scholar
  27. [27]
    J. Lecompte, J. Grevisse andM.L. Beaumariage,Potentiation par l'hydrocortisone des effects moteurs de l'adrenaline, Arch. int. Pharmacodyn.119, 133–141 (1959).PubMedGoogle Scholar
  28. [28]
    J.C. Besse andA.D. Bass,Potentiation by hydrocortisone of responses to catecholamines in vascular smooth muscle, J. Pharm. Exptl. Ther.154, 224–238 (1966).Google Scholar
  29. [29]
    S. Kalsner,Steroid potentiation of responses to sympathomimetic amines in aortic strips, Br. J. Pharmac.36, 582–593 (1969).Google Scholar
  30. [30]
    B.M. Altura,Role of glucocorticoids in local regulation of blood flow, Am. J. Physiol.211, 1393–1397 (1966).PubMedGoogle Scholar
  31. [31]
    J. Friedland, C. Setton andE. Silverstein,Angiotensin Converting Enzyme: induction by Steroids in Rabbit Alveolar Macrophages in Culture, Science197, 64–65 (1977).PubMedGoogle Scholar
  32. [32]
    F.A.O. Mendelsohn, C.J. Lloyd, C. Kachel andJ.W. Funder,Induction by Glucocorticoids of Angiotensin Converting Enzyme Production from Bovine Endothelial Cells in Culture and Rat Lung in vivo, J. Clin. Invest.70, 684–692 (1982).PubMedGoogle Scholar
  33. [33]
    K.K.F. Ng andJ.R. Vane,The conversion of angiotensin I to Angiotensin II, Nature126, 762–766 (1967).Google Scholar
  34. [34]
    Y.S. Bakhle, A.M. Reynard andJ.R. Vane,Metabolism of the Angiotensins in Isolated Perfused Tissues, Nature222, 956–959 (1969).Google Scholar
  35. [35]
    B.G. Zimmerman,Actions of angiotensin on adrenergic nerve endings, Fed. Proc.37, 199–202 (1978).Google Scholar

Copyright information

© Birkhäuser Verlag 1985

Authors and Affiliations

  • M. Di Rosa
    • 1
  • A. Calignano
    • 1
  • R. Carnuccio
    • 1
  • A. Ialenti
    • 1
  • L. Sautebin
    • 1
  1. 1.Department of Experimental PharmacologyUniversity of NaplesItaly

Personalised recommendations